[CLSTR]
< Back to situation

[REVISION HISTORY]

Philip Morris operations and economic impact in Europe

Updated 2 times since CLSTR started tracking revisions of this situation.

What changed

2026-10-21 20:23 UTC → 2026-10-23 09:15 UTC · added removed

Philip Morris International (PMI) has demonstrated a complex economic and operational presence in Europe. In the first half of 2026, the company reported varied financial outcomes across specific regional markets. In Serbia, revenues increased to 20.7 billion dinars, though net profit fell to 3.7 billion dinars due to rising operating expenses. In the Czech Republic, net profit dropped by 7.2% to 1.49 billion CZK, driven by declining traditional cigarette volumes and unfavorable exchange rates, despite growth in the smokeless category. The company also noted a decline in market share in both the Czech Republic (39.6%) and Slovakia (48.9%). An EY-Parthenon study detailed PMI’s economic footprint in the European Union between 2021 and 2025, noting a contribution of nearly €343 billion. This includes €22.3 billion spent with European suppliers, €27.4 billion invested in European operations, and €39.5 billion in exports. In Germany, the company reported €7.4 billion in spending and investments, including €4.8 billion directed toward German suppliers. The company’s activities supported approximately 164,000 jobs in 2025, including 22,500 direct positions. Research and development efforts included €422 million invested across Europe and approximately €2.2 billion in R&D activities in Switzerland. 2025. As part of a long-term corporate strategy, PMI is transitioning from traditional tobacco to alternative products. By the fourth third quarter of 2025, more than half of the company’s net revenues in Europe were derived from smoke-free products. Globally, 2026, smoke-free products accounted for more than products, including IQOS, VEEV, and ZYN, surpassed 40% of total net revenues across 110 markets as of the third quarter of markets. Globally, net revenue rose 5.5% to $11.44 billion in Q3 2026. This transition is supported by over $16 billion in global R&D investments since 2008 2008. However, the company noted decelerating growth for technologies such as heated tobacco, nicotine pouches, ZYN in the United States and e-vapor products. rising cost pressures stemming from geopolitical tensions in the Middle East and operational disruptions in Ukraine.

Versions

  1. 2026-10-23 09:15 UTC Philip Morris operations and economic impact in Europe
  2. 2026-10-21 20:23 UTC Philip Morris operations and economic impact in Europe
  3. 2026-10-15 21:29 UTC Philip Morris operations and economic impact in Europe

Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.